PH30917A - Novel cyclosporin galenic forms. - Google Patents
Novel cyclosporin galenic forms.Info
- Publication number
- PH30917A PH30917A PH40014A PH40014A PH30917A PH 30917 A PH30917 A PH 30917A PH 40014 A PH40014 A PH 40014A PH 40014 A PH40014 A PH 40014A PH 30917 A PH30917 A PH 30917A
- Authority
- PH
- Philippines
- Prior art keywords
- galenic forms
- novel cyclosporin
- cyclosporin galenic
- novel
- forms
- Prior art date
Links
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 title 1
- 229930105110 Cyclosporin A Natural products 0.000 title 1
- 108010036949 Cyclosporine Proteins 0.000 title 1
- 229960001265 ciclosporin Drugs 0.000 title 1
- 229930182912 cyclosporin Natural products 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Pain & Pain Management (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Tropical Medicine & Parasitology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Inorganic Chemistry (AREA)
- Neurology (AREA)
- Biophysics (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB898902901A GB8902901D0 (en) | 1989-02-09 | 1989-02-09 | Improvements in or relating to organic compounds |
| GB898902898A GB8902898D0 (en) | 1989-02-09 | 1989-02-09 | Improvements in or relating to organic compounds |
| GB898903147A GB8903147D0 (en) | 1989-02-13 | 1989-02-13 | Improvements in or relating to organic compounds |
| GB898903663A GB8903663D0 (en) | 1989-02-17 | 1989-02-17 | Improvements in or relating to organic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH30917A true PH30917A (en) | 1997-12-23 |
Family
ID=27450262
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH40014A PH30917A (en) | 1989-02-09 | 1990-02-07 | Novel cyclosporin galenic forms. |
Country Status (25)
| Country | Link |
|---|---|
| JP (3) | JP3484190B2 (en) |
| KR (1) | KR0170769B1 (en) |
| AT (1) | AT404552B (en) |
| AU (1) | AU630413B2 (en) |
| BE (1) | BE1003009A5 (en) |
| CA (1) | CA2009533C (en) |
| CH (1) | CH679277A5 (en) |
| CY (1) | CY1903A (en) |
| DE (1) | DE4003844B4 (en) |
| DK (1) | DK176209B1 (en) |
| ES (1) | ES2021942A6 (en) |
| FI (1) | FI97524C (en) |
| FR (1) | FR2642650B1 (en) |
| GB (1) | GB2230440B (en) |
| HK (1) | HK37296A (en) |
| HU (1) | HU213394B (en) |
| IT (1) | IT1240758B (en) |
| LU (1) | LU87675A1 (en) |
| MY (1) | MY107377A (en) |
| NL (1) | NL195028C (en) |
| NO (1) | NO301576B1 (en) |
| NZ (1) | NZ232401A (en) |
| PH (1) | PH30917A (en) |
| PT (1) | PT93079B (en) |
| SE (1) | SE511398C2 (en) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2222770B (en) * | 1988-09-16 | 1992-07-29 | Sandoz Ltd | Pharmaceutical compositions containing cyclosporins |
| HU208491B (en) * | 1990-11-27 | 1993-11-29 | Gyogyszerkutato Intezet | Process for producing oral pharmaceutical composition containing cyclosporin |
| MX9201782A (en) † | 1991-04-19 | 1992-10-01 | Sandoz Ag | PARTICLES OF BIOLOGICALLY ACTIVE SUBSTANCES, SUBSTANTIALLY INSOLUBLE IN WATER, PROCESS FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM. |
| GB9113872D0 (en) * | 1991-06-27 | 1991-08-14 | Sandoz Ag | Improvements in or relating to organic compounds |
| US6262022B1 (en) | 1992-06-25 | 2001-07-17 | Novartis Ag | Pharmaceutical compositions containing cyclosporin as the active agent |
| HK1004520A1 (en) | 1992-05-13 | 1998-11-27 | Novartis Ag | Ophthalmic compositions containing a cyclosporin |
| US5759566A (en) * | 1992-07-28 | 1998-06-02 | Poli Industria Chimica Spa | Microemulsion pharmaceutical compositions for the delivery of pharmaceutically active agents |
| DK0589843T3 (en) | 1992-09-25 | 2002-04-02 | Novartis Ag | Cyclosporin-containing pharmaceutical preparations |
| DE4412201A1 (en) * | 1993-04-20 | 1994-11-10 | Rentschler Arzneimittel | New pharmaceutical preparations for oral administration containing cyclosporin |
| CA2161143A1 (en) * | 1993-04-20 | 1994-10-27 | Monika Fleck | New pharmaceutical preparations comprising cyclosporin for oral administration |
| DE4340781C3 (en) * | 1993-11-30 | 2000-01-27 | Novartis Ag | Liquid preparations containing cyclosporin and process for their preparation |
| KR0146671B1 (en) * | 1994-02-25 | 1998-08-17 | 김충환 | Cyclosporin-containing powder composition |
| CA2231404C (en) | 1994-11-03 | 2009-02-17 | Arzneimittelwerk Dresden Gmbh | Novel cyclosporine preparation forms for oral administration of simple composition and high bio-availability, and process for producing them |
| US5679566A (en) * | 1995-01-20 | 1997-10-21 | University Of Massachusetts Medical Center | Yeast NMD2 gene |
| US5766629A (en) | 1995-08-25 | 1998-06-16 | Sangstat Medical Corporation | Oral cyclosporin formulations |
| US5962019A (en) * | 1995-08-25 | 1999-10-05 | Sangstat Medical Corporation | Oral cyclosporin formulations |
| US5834017A (en) * | 1995-08-25 | 1998-11-10 | Sangstat Medical Corporation | Oral cyclopsporin formulations |
| US5827822A (en) * | 1996-03-25 | 1998-10-27 | Sangstat Medical Corporation | Cyclosporin a formulations as nanoparticles |
| DE19544507B4 (en) | 1995-11-29 | 2007-11-15 | Novartis Ag | Cyclosporin containing preparations |
| US5798333A (en) * | 1996-09-17 | 1998-08-25 | Sherman; Bernard C. | Water-soluble concentrates containing cyclosporins |
| AU762247B2 (en) * | 1997-01-30 | 2003-06-19 | Novartis Ag | Oil-free pharmaceutical compositions containing cyclosporin A |
| KR20050084502A (en) | 1997-01-30 | 2005-08-26 | 노파르티스 아게 | Oil-free pharmaceutical compositions containing cyclosporin a |
| CZ301382B6 (en) * | 1997-03-12 | 2010-02-10 | Abbott Laboratories Chad377/Ap6D-2 | Hydrophilic binary systems for administering cyclosporin |
| NZ328751A (en) * | 1997-09-16 | 1999-01-28 | Bernard Charles Sherman | Solid medicament containing an anionic surfactant and cyclosporin |
| US6447806B1 (en) | 1999-02-25 | 2002-09-10 | Novartis Ag | Pharmaceutical compositions comprised of stabilized peptide particles |
| EP1435910B9 (en) | 2001-10-19 | 2010-02-03 | Isotechnika Inc. | Novel cyclosporin analog microemulsion preconcentrates |
| US6979672B2 (en) | 2002-12-20 | 2005-12-27 | Polichem, S.A. | Cyclosporin-based pharmaceutical compositions |
| JP4521554B2 (en) * | 2004-03-31 | 2010-08-11 | マイラン製薬株式会社 | Cyclosporine preparation |
| WO2007050975A2 (en) * | 2005-10-26 | 2007-05-03 | Banner Pharmacaps, Inc. | Hydrophilic vehicle-based dual controlled release matrix system as capsule fill |
| MX2008012495A (en) | 2006-03-28 | 2009-01-07 | Javelin Pharmaceuticals Inc | Formulations of low dose diclofenac and beta-cyclodextrin. |
| US7495024B2 (en) | 2006-08-07 | 2009-02-24 | Via Pharmaceuticals, Inc. | Phenylalkyl N-hydroxyureas for combating atherosclerotic plaque |
| DE102008059201A1 (en) | 2008-11-27 | 2010-06-02 | GÖPFERICH, Achim, Prof. Dr. | In situ precipitating drug solutions |
| KR102146704B1 (en) | 2018-04-13 | 2020-08-21 | 가천대학교 산학협력단 | Cyclosporin a containing microstructures for transdermal and intradermal drug delivery |
| KR20240070705A (en) * | 2021-10-13 | 2024-05-21 | 추가이 세이야쿠 가부시키가이샤 | Compositions Comprising Peptide Compounds and Surfactants |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI65914C (en) * | 1978-03-07 | 1984-08-10 | Sandoz Ag | FRAMEWORK FOR PHARMACEUTICAL COMPOSITION OF CYCLOSPORINE A |
| JPS61280435A (en) * | 1985-04-04 | 1986-12-11 | Kanji Takada | Lymph orienting preparation of cyclosporin |
| NL8600050A (en) * | 1986-01-13 | 1987-08-03 | Sanico Nv | PHARMACEUTICAL PREPARATION WITH DELAYED DELIVERY OF THE ACTIVE SUBSTANCE AND METHOD FOR PREPARING IT. |
| GB8602372D0 (en) * | 1986-01-31 | 1986-03-05 | Sandoz Ltd | Organic compounds |
| CA1290249C (en) * | 1986-04-09 | 1991-10-08 | Cetus Corporation | COMBINATION THERAPY USING INTERLEUKIN-2 AND/OR INTERFERON-.beta. AND TUMOR NECROSIS FACTOR |
| EP0267615A3 (en) * | 1986-11-13 | 1989-05-03 | Sloan-Kettering Institute For Cancer Research | Compositions and method for treatment of cancer using monoclonal antibody against gd3 ganglioside together with il-2 |
| EP0296122B1 (en) * | 1987-06-17 | 1993-09-29 | Sandoz Ag | Cyclosporins and their use as pharmaceuticals |
| JP2536876B2 (en) * | 1987-07-31 | 1996-09-25 | 寛治 高田 | Dissolvable powder formulation of cyclosporine |
| HU205010B (en) * | 1987-09-15 | 1992-03-30 | Sandoz Ag | Process for producing pharmaceutical compositions comprising compounds soluble up to 1 per cent and having medical activity |
| US5756450A (en) * | 1987-09-15 | 1998-05-26 | Novartis Corporation | Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceutical excipients and novel cyclosporin galenic forms |
| DE3830494B4 (en) * | 1987-09-15 | 2006-05-18 | Novartis Ag | Water-soluble monoesters as solubilizers for pharmacologically active substances and pharmaceutical excipients |
| JP2792862B2 (en) * | 1988-07-30 | 1998-09-03 | 寛治 高田 | Oral enteric formulation |
| GB2222770B (en) * | 1988-09-16 | 1992-07-29 | Sandoz Ltd | Pharmaceutical compositions containing cyclosporins |
| JPH1038029A (en) * | 1996-07-26 | 1998-02-13 | Ebara Corp | Dick shape structure with vibration damping function |
| JPH10280435A (en) * | 1997-04-03 | 1998-10-20 | Sekisui Chem Co Ltd | Construction method of basement |
-
1990
- 1990-02-05 GB GB9002504A patent/GB2230440B/en not_active Expired - Lifetime
- 1990-02-05 CH CH359/90A patent/CH679277A5/de not_active IP Right Cessation
- 1990-02-05 BE BE9000133A patent/BE1003009A5/en not_active IP Right Cessation
- 1990-02-05 FR FR9001389A patent/FR2642650B1/en not_active Expired - Lifetime
- 1990-02-07 PH PH40014A patent/PH30917A/en unknown
- 1990-02-07 LU LU87675A patent/LU87675A1/en unknown
- 1990-02-07 HU HU90701A patent/HU213394B/en unknown
- 1990-02-07 CA CA002009533A patent/CA2009533C/en not_active Expired - Lifetime
- 1990-02-07 NZ NZ232401A patent/NZ232401A/en unknown
- 1990-02-07 FI FI900604A patent/FI97524C/en active IP Right Grant
- 1990-02-07 PT PT93079A patent/PT93079B/en not_active IP Right Cessation
- 1990-02-07 NO NO900577A patent/NO301576B1/en not_active IP Right Cessation
- 1990-02-07 SE SE9000441A patent/SE511398C2/en not_active Application Discontinuation
- 1990-02-07 MY MYPI90000191A patent/MY107377A/en unknown
- 1990-02-07 DK DK199000327A patent/DK176209B1/en not_active IP Right Cessation
- 1990-02-08 KR KR1019900001492A patent/KR0170769B1/en not_active Expired - Lifetime
- 1990-02-08 AU AU49252/90A patent/AU630413B2/en not_active Expired
- 1990-02-08 DE DE4003844A patent/DE4003844B4/en not_active Expired - Lifetime
- 1990-02-08 JP JP03134890A patent/JP3484190B2/en not_active Expired - Lifetime
- 1990-02-08 IT IT47609A patent/IT1240758B/en active IP Right Grant
- 1990-02-08 AT AT0027290A patent/AT404552B/en not_active IP Right Cessation
- 1990-02-08 NL NL9000299A patent/NL195028C/en not_active IP Right Cessation
- 1990-02-09 ES ES9000397A patent/ES2021942A6/en not_active Expired - Lifetime
-
1996
- 1996-03-07 HK HK37296A patent/HK37296A/en not_active IP Right Cessation
- 1996-11-22 CY CY190396A patent/CY1903A/en unknown
-
2001
- 2001-04-25 JP JP2001127538A patent/JP4073641B2/en not_active Expired - Lifetime
-
2005
- 2005-09-13 JP JP2005265724A patent/JP2006001947A/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH30917A (en) | Novel cyclosporin galenic forms. | |
| GB2228198B (en) | Novel cyclosporin galenic forms | |
| DE69014117D1 (en) | Radiotherapiesystem. | |
| EP0593428A4 (en) | Myconematicide. | |
| DE69000624D1 (en) | Schliessmechanismus. | |
| DE69000353D1 (en) | Fluegelzellenmaschine. | |
| DE69012800D1 (en) | Hüftprothese. | |
| GR3018421T3 (en) | Glutarimides. | |
| DE69001591D1 (en) | Tuerschliesser. | |
| DE69013160D1 (en) | Reibscheibentoroidgetriebe. | |
| DE68907587D1 (en) | Trappingssystem. | |
| DE69013161D1 (en) | Reibscheibentoroidalgetriebe. | |
| GB2235734B (en) | Turbo-rotor construction. | |
| OA09196A (en) | "Tétrahydroimidazo (1,4) benzodiazépin-2-thiones antivirales". | |
| DE59001953D1 (en) | Interferometeranordnung. | |
| DE59008181D1 (en) | Trifluormethylcyclohexan-derivate. | |
| DE59006531D1 (en) | Interferometeranordnung. | |
| DE69022965D1 (en) | Aminopiperazinderivate. | |
| DE69008186D1 (en) | Allylhydroperoxidkettenübertragungsmittel. | |
| ZA904897B (en) | Vip-analogs ii. | |
| DE69002778D1 (en) | Pyrolytisches bornitrid. | |
| DE59001720D1 (en) | Spruehvorrichtung. | |
| DE59000988D1 (en) | Brueckenuntersichtvorrichtung. | |
| ZA903177B (en) | N-sulfenyl-and n-sulfinyl-n,n'-diacylhydrazides | |
| DE69001652D1 (en) | Tuerschliesser. |